These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38665259)

  • 1. Persistent hypercalcaemia associated with two pathogenic variants in the
    Leszczyńska D; Szatko A; Latocha J; Kochman M; Duchnowska M; Wójcicka A; Misiorowski W; Zgliczyníski W; Glinicki P
    Front Endocrinol (Lausanne); 2024; 15():1355916. PubMed ID: 38665259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CYP24A1 gene defect manifesting with gestational hypercalcemia].
    Györkös A; Tőke J; Sohár G; Kovács M; Goldfinger J; Vajda G; Kalmár T; Tóth M
    Orv Hetil; 2022 Jul; 163(31):1237-1242. PubMed ID: 35908214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of vitamin D
    Kowalska E; Rola R; Wójcik M; Łaszcz N; Płudowski P; Wierzbicka A; Janiec A; Książyk J; Halat P; Ciara E; Obrycki Ł; Pronicka E; Litwin M
    J Steroid Biochem Mol Biol; 2021 Apr; 208():105824. PubMed ID: 33516786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.
    Molin A; Baudoin R; Kaufmann M; Souberbielle JC; Ryckewaert A; Vantyghem MC; Eckart P; Bacchetta J; Deschenes G; Kesler-Roussey G; Coudray N; Richard N; Wraich M; Bonafiglia Q; Tiulpakov A; Jones G; Kottler ML
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1343-52. PubMed ID: 26214117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypervitaminosis D Secondary to a
    Collins L; Boehm E; Luxford C; Clifton-Bligh R; Grill V
    JBMR Plus; 2023 Sep; 7(9):e10788. PubMed ID: 37701149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intractable hypercalcaemia during pregnancy and the postpartum secondary to pathogenic variants in CYP24A1.
    Arnold N; O'Toole V; Huynh T; Smith HC; Luxford C; Clifton-Bligh R; Eastman CJ
    Endocrinol Diabetes Metab Case Rep; 2019 Nov; 2019():. PubMed ID: 31751313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure.
    Colussi G; Ganon L; Penco S; De Ferrari ME; Ravera F; Querques M; Primignani P; Holtzman EJ; Dinour D
    Nephrol Dial Transplant; 2014 Mar; 29(3):636-43. PubMed ID: 24235083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the
    Cappellani D; Brancatella A; Kaufmann M; Minucci A; Vignali E; Canale D; De Paolis E; Capoluongo E; Cetani F; Jones G; Marcocci C
    Case Rep Endocrinol; 2019; 2019():4982621. PubMed ID: 31089432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Screening Test for Idiopathic Infantile Hypercalcemia Confirms Residual Levels of Serum 24,25-(OH)
    Kaufmann M; Morse N; Molloy BJ; Cooper DP; Schlingmann KP; Molin A; Kottler ML; Gallagher JC; Armas L; Jones G
    J Bone Miner Res; 2017 Jul; 32(7):1589-1596. PubMed ID: 28304097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of the survivors of infantile hypercalcaemia with CYP24A1 and SLC34A1 mutations.
    Janiec A; Halat-Wolska P; Obrycki Ł; Ciara E; Wójcik M; Płudowski P; Wierzbicka A; Kowalska E; Książyk JB; Kułaga Z; Pronicka E; Litwin M
    Nephrol Dial Transplant; 2021 Jul; 36(8):1484-1492. PubMed ID: 33099630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do the Heterozygous Carriers of a CYP24A1 Mutation Display a Different Biochemical Phenotype Than Wild Types?
    Brancatella A; Cappellani D; Kaufmann M; Borsari S; Piaggi P; Baldinotti F; Caligo MA; Jones G; Marcocci C; Cetani F
    J Clin Endocrinol Metab; 2021 Mar; 106(3):708-717. PubMed ID: 33249478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP24A1 loss of function: Clinical phenotype of monoallelic and biallelic mutations.
    Carpenter TO
    J Steroid Biochem Mol Biol; 2017 Oct; 173():337-340. PubMed ID: 28093352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP24A1 and SLC34A1 Pathogenic Variants Are Uncommon in a Canadian Cohort of Children with Hypercalcemia or Hypercalciuria.
    Rousseau-Nepton I; Jones G; Schlingmann K; Kaufmann M; Zuijdwijk CS; Khatchadourian K; Gupta IR; Pacaud D; Pinsk MN; Mokashi A; Nour MA; Alexander RT; Rodd CJ
    Horm Res Paediatr; 2021; 94(3-4):124-132. PubMed ID: 34320495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Contribution of Cyp24a1 Promoter Vitamin D Response Elements.
    Meyer MB; Lee SM; Towne JM; Cichanski SR; Kaufmann M; Jones G; Pike JW
    Endocrinology; 2024 Sep; 165(11):. PubMed ID: 39363152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iatrogenic vitamin D toxicity in an infant--a case report and review of literature.
    Ketha H; Wadams H; Lteif A; Singh RJ
    J Steroid Biochem Mol Biol; 2015 Apr; 148():14-8. PubMed ID: 25636720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
    Kaufmann M; Lee SM; Pike JW; Jones G
    Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypercalcemia and inactive mutation of CYP24A1. Case-study and literature review].
    Seidowsky A; Villain C; Vilaine E; Baudoin R; Tabarin A; Kottler ML; Cavalier É; Souberbielle JC; Massy ZA
    Nephrol Ther; 2017 May; 13(3):146-153. PubMed ID: 28456639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperparathyroidism complicating CYP 24A1 mutations.
    Loyer C; Leroy C; Molin A; Odou MF; Huglo D; Lion G; Ernst O; Hoffmann M; Porchet N; Carnaille B; Pattou F; Kottler ML; Vantyghem MC
    Ann Endocrinol (Paris); 2016 Oct; 77(5):615-619. PubMed ID: 27378451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LC-MS/MS for Identifying Patients with CYP24A1 Mutations.
    Ketha H; Kumar R; Singh RJ
    Clin Chem; 2016 Jan; 62(1):236-42. PubMed ID: 26585929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.